Intra-Cellular Therapies Price to Book Ratio 2013-2020 | ITCI

Historical price to book ratio values for Intra-Cellular Therapies (ITCI) over the last 10 years. The current price to book ratio for Intra-Cellular Therapies as of December 03, 2020 is 2.39.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Intra-Cellular Therapies Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2020-12-04 25.17 2.84
2020-09-30 25.66 $8.85 2.90
2020-06-30 25.67 $5.68 4.52
2020-03-31 15.37 $6.50 2.36
2019-12-31 34.31 $3.51 9.77
2019-09-30 7.47 $4.11 1.82
2019-06-30 12.98 $4.65 2.79
2019-03-31 12.18 $5.24 2.33
2018-12-31 11.39 $5.79 1.97
2018-09-30 21.70 $6.46 3.36
2018-06-30 17.67 $7.14 2.48
2018-03-31 21.05 $7.74 2.72
2017-12-31 14.48 $8.32 1.74
2017-09-30 15.78 $7.36 2.15
2017-06-30 12.42 $7.82 1.59
2017-03-31 16.25 $8.13 2.00
2016-12-31 15.09 $8.67 1.74
2016-09-30 15.24 $9.23 1.65
2016-06-30 38.82 $9.85 3.94
2016-03-31 27.80 $10.47 2.65
2015-12-31 53.79 $11.04 4.87
2015-09-30 40.04 $11.67 3.43
2015-06-30 31.95 $5.81 5.50
2015-03-31 23.88 $6.36 3.76
2014-12-31 17.65 $4.09 4.32
2014-09-30 13.71 $4.56 3.01
2014-06-30 16.86 $4.72 3.57
2014-03-31 18.18 $4.88 3.72
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.015B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.694B 10.03
Amgen (AMGN) United States $131.896B 13.79
CSL (CSLLY) Australia $100.576B 0.00
Gilead Sciences (GILD) United States $76.628B 10.19
Vertex Pharmaceuticals (VRTX) United States $58.951B 27.41
Moderna (MRNA) United States $56.587B 0.00
Regeneron Pharmaceuticals (REGN) United States $53.901B 19.12
Illumina (ILMN) United States $49.760B 68.44
Biogen (BIIB) United States $37.996B 6.75
Seagen (SGEN) United States $31.921B 84.31
BioNTech SE (BNTX) Germany $27.398B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.863B 10.70
Genmab (GMAB) Denmark $25.117B 29.70
Genmab (GNMSF) Denmark $23.856B 5.49
BeiGene (BGNE) Cayman Islands $20.611B 0.00
Exact Sciences (EXAS) United States $18.714B 0.00
Incyte (INCY) United States $18.017B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.183B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.596B 62.94
Horizon Therapeutics Public (HZNP) Ireland $15.348B 21.94
Alnylam Pharmaceuticals (ALNY) United States $15.042B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.497B 96.22
ARGENX SE-ADR (ARGX) Netherlands $13.533B 0.00
Guardant Health (GH) United States $11.962B 0.00
Sarepta Therapeutics (SRPT) United States $11.835B 0.00
Bio-Techne Corp (TECH) United States $11.518B 73.66
Mirati Therapeutics (MRTX) United States $11.387B 0.00
QIAGEN (QGEN) Netherlands $10.873B 24.48
Repligen (RGEN) United States $9.840B 139.55
CRISPR Therapeutics AG (CRSP) Switzerland $9.294B 0.00
Ascendis Pharma (ASND) Denmark $8.987B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.701B 0.00
Galapagos (GLPG) Belgium $8.156B 0.00
Novavax (NVAX) United States $7.988B 0.00
Denali Therapeutics (DNLI) United States $7.497B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.202B 0.00
Acceleron Pharma (XLRN) United States $7.036B 0.00
Adaptive Biotechnologies (ADPT) United States $6.523B 0.00
Amicus Therapeutics (FOLD) United States $6.053B 0.00
Exelixis (EXEL) United States $5.997B 40.27
Blueprint Medicines (BPMC) United States $5.886B 19.49
SWEDISH ORP BIO (BIOVF) Sweden $5.829B 15.93
Halozyme Therapeutics (HALO) United States $5.497B 254.13
Fate Therapeutics (FATE) United States $5.281B 0.00
NeoGenomics (NEO) United States $5.247B 1575.17
Twist Bioscience (TWST) United States $5.196B 0.00
China Biologic Products (CBPO) China $4.677B 30.31
Reata Pharmaceuticals (RETA) United States $4.625B 0.00
Emergent Biosolutions (EBS) United States $4.343B 14.25
Insmed (INSM) United States $4.049B 0.00
Vir Biotechnology (VIR) United States $3.944B 0.00
Legend Biotech (LEGN) United States $3.935B 0.00
Arena Pharmaceuticals (ARNA) United States $3.820B 0.00
MorphoSys AG (MOR) Germany $3.718B 134.57
Eidos Therapeutics (EIDX) United States $3.468B 0.00
Beam Therapeutics (BEAM) United States $3.317B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.237B 0.00
Bluebird Bio (BLUE) United States $3.066B 0.00
Alkermes (ALKS) Ireland $2.995B 29.41
Global Blood Therapeutics (GBT) United States $2.767B 0.00
Zymeworks (ZYME) Canada $2.511B 0.00
Intellia Therapeutics (NTLA) United States $2.427B 0.00
Seres Therapeutics (MCRB) United States $2.293B 0.00
UniQure (QURE) Netherlands $2.255B 0.00
Viela Bio (VIE) United States $2.193B 0.00
PHARMA MAR SA (PHMMF) Spain $2.148B 0.00
I-Mab (IMAB) China $2.118B 0.00
Sorrento Therapeutics (SRNE) United States $2.043B 0.00
Alcobra (ARCT) United States $2.040B 0.00
Inovio Pharmaceuticals (INO) United States $2.028B 0.00
Editas Medicine (EDIT) United States $1.967B 0.00
Amarin (AMRN) Ireland $1.893B 0.00
Mesoblast (MESO) Australia $1.858B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.834B 0.00
Arcus Biosciences (RCUS) United States $1.764B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.688B 0.00
Scholar Rock Holding (SRRK) United States $1.680B 0.00
NGM Biopharmaceuticals (NGM) United States $1.646B 0.00
Mersana Therapeutics (MRSN) United States $1.612B 0.00
Revance Therapeutics (RVNC) United States $1.609B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Precigen (PGEN) United States $1.586B 0.00
Zealand Pharma (ZEAL) Denmark $1.511B 0.00
Sangamo Therapeutics (SGMO) United States $1.412B 0.00
REGENXBIO (RGNX) United States $1.410B 0.00
Myriad Genetics (MYGN) United States $1.394B 0.00
Adverum Biotechnologies (ADVM) United States $1.367B 0.00
Epizyme (EPZM) United States $1.359B 0.00
Coherus BioSciences (CHRS) United States $1.358B 8.98
Ligand Pharmaceuticals (LGND) United States $1.342B 34.77
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Cytokineticsorporated (CYTK) United States $1.274B 0.00
Athenex (ATNX) United States $1.264B 0.00
Northwest Biotherapeutics (NWBO) United States $1.247B 0.00
Genetron Holdings (GTH) China $1.211B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.208B 0.00
Travere Therapeutics (TVTX) United States $1.194B 0.00
Heska (HSKA) United States $1.160B 0.00
Vericel (VCEL) United States $1.130B 0.00
Cellectis S.A (CLLS) France $1.129B 0.00
Codexis (CDXS) United States $1.119B 0.00
Alector (ALEC) United States $1.099B 0.00
Arvinas (ARVN) United States $1.024B 0.00
Pliant Therapeutics (PLRX) United States $1.011B 0.00
Castle Biosciences (CSTL) United States $1.002B 0.00
NantKwest (NK) United States $0.989B 0.00
Morphic Holding (MORF) United States $0.971B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.931B 0.00
Frequency Therapeutics (FREQ) United States $0.921B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.884B 0.00
Pharming Group (PHGUF) Netherlands $0.876B 20.00
Celldex Therapeutics (CLDX) United States $0.866B 0.00
Compugen (CGEN) Israel $0.859B 0.00
Protagonist Therapeutics (PTGX) United States $0.841B 0.00
Cardiff Oncology (CRDF) United States $0.788B 0.00
VBI Vaccines (VBIV) United States $0.784B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
MiMedx (MDXG) United States $0.742B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.738B 37.47
Kadmon Holdings (KDMN) United States $0.732B 0.00
Albireo Pharma (ALBO) United States $0.718B 0.00
Agenus (AGEN) United States $0.690B 0.00
AnaptysBio (ANAB) United States $0.676B 0.00
MannKind (MNKD) United States $0.670B 0.00
Five Prime Therapeutics (FPRX) United States $0.661B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.637B 0.00
Sutro Biopharma (STRO) United States $0.631B 0.00
Precision BioSciences (DTIL) United States $0.609B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.598B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.594B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.592B 0.00
Dynavax Technologies (DVAX) United States $0.578B 0.00
IVERIC Bio (ISEE) United States $0.575B 0.00
Geron (GERN) United States $0.556B 0.00
MeiraGTx Holdings (MGTX) United States $0.542B 0.00
Avid Bioservices (CDMO) United States $0.538B 0.00
Anika Therapeutics (ANIK) United States $0.527B 71.29
Merus (MRUS) Netherlands $0.524B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.517B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.511B 0.00
Forte Biosciences (FBRX) United States $0.500B 0.00
Cel-Sci (CVM) United States $0.478B 0.00
Spero Therapeutics (SPRO) United States $0.470B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.461B 0.00
Puma Biotechnology (PBYI) United States $0.455B 0.00
WAVE Life Sciences (WVE) Singapore $0.448B 0.00
Prothena (PRTA) Ireland $0.442B 0.00
Cue Biopharma (CUE) United States $0.434B 0.00
Clovis Oncology (CLVS) United States $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.429B 0.00
Kala Pharmaceuticals (KALA) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.418B 0.00
Innate Pharma S.A (IPHA) France $0.408B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.404B 0.00
AC Immune SA (ACIU) Switzerland $0.400B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.398B 0.00
Affimed (AFMD) Germany $0.397B 0.00
Starpharma Holdings (SPHRY) Australia $0.396B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 18.33
Trevena (TRVN) United States $0.377B 0.00
Selecta Biosciences (SELB) United States $0.368B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.366B 0.00
Cellular Biomedicine (CBMG) United States $0.363B 0.00
Verastem (VSTM) United States $0.360B 0.00
XOMA (XOMA) United States $0.358B 0.00
Athersys (ATHX) United States $0.352B 0.00
Syros Pharmaceuticals (SYRS) United States $0.350B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 8.90
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Arbutus Biopharma (ABUS) United States $0.335B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.305B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Kamada (KMDA) Israel $0.301B 14.06
IBio (IBIO) United States $0.290B 0.00
PDL BioPharma (PDLI) United States $0.289B 0.00
NextCure (NXTC) United States $0.283B 0.00
CorMedix Inc (CRMD) United States $0.276B 0.00
Pluristem Therapeutics (PSTI) Israel $0.269B 0.00
DBV Technologies S.A (DBVT) France $0.267B 0.00
Fortress Biotech (FBIO) United States $0.262B 0.00
AquaBounty Technologies (AQB) United States $0.256B 0.00
HOOKIPA Pharma (HOOK) United States $0.240B 0.00
Aptinyx (APTX) United States $0.237B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.228B 0.00
TELA Bio (TELA) United States $0.219B 0.00
Nicox SA (NICXF) France $0.207B 0.00
GENFIT S.A (GNFT) France $0.203B 0.00
Aptevo Therapeutics (APVO) United States $0.198B 0.00
Eton Pharmaceuticals (ETON) United States $0.195B 0.00
ADMA Biologics Inc (ADMA) United States $0.188B 0.00
Bellus Health (BLU) Canada $0.186B 0.00
Cerecor (CERC) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.183B 0.00
Idera Pharmaceuticals (IDRA) United States $0.183B 0.00
Theratechnologies (THTX) Canada $0.182B 0.00
Checkpoint Therapeutics (CKPT) United States $0.174B 0.00
Dyadic (DYAI) United States $0.165B 0.00
SESEN BIO, INC (SESN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VolitionRX (VNRX) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.158B 0.00
Abeona Therapeutics (ABEO) United States $0.154B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
Kindred Biosciences (KIN) United States $0.151B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Oncobiologics (OTLK) United States $0.148B 0.00
Cogent Biosciences (COGT) United States $0.138B 0.00
Celyad SA (CYAD) Belgium $0.130B 0.00
Applied Genetic Technologies (AGTC) United States $0.129B 0.00
Exicure (XCUR) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Lumos Pharma (LUMO) United States $0.128B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Aytu Bioscience (AYTU) United States $0.112B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Curis (CRIS) United States $0.111B 0.00
Windtree Therapeutics (WINT) United States $0.109B 0.00
Orgenesis (ORGS) United States $0.106B 220.00
Palatin Technologies (PTN) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Cyclerion Therapeutics (CYCN) United States $0.104B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Prometic Life Sciences (LMNL) Canada $0.099B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
Novogen (KZIA) Australia $0.095B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Evogene (EVGN) Israel $0.087B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.076B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Soligenix (SNGX) United States $0.069B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.63
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Vascular Biogenics (VBLT) Israel $0.062B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.057B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Seelos Therapeutics (SEEL) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
ATyr Pharma (LIFE) United States $0.043B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
BioCardia (BCDA) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Celsion (CLSN) United States $0.022B 0.00
Spherix (AIKI) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Advaxis (ADXS) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00